A ruthenium anticancer compound interacts with histones and impacts differently on epigenetic and death pathways compared to cisplatin

por Licona, Cynthia, Spaety, Marie-Elodie, Capuozzo, Antonelle, Ali, Moussa, Santamaria, Rita, Armant, Olivier, Delalande, Francois, Dorsselaer, Alain Van, Cianferani, Sarah, Spencer, John, Pfeffer, Michel, Mellitzer, Georg, Gaiddon, Christian
Publicado 2016